Treating type 1 diabetes mellitus (T1D) is a challenge for patients, their families, and multidisciplinary care teams due to the disease's characteristics, the use of insulin and the constant monitoring of blood glucose levels. This evidence concerns the gene INS and type 1 diabetes mellitus.